Clinical Trial Update: Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer [Phase 3]

View source ↗

Summary

This clinical trial update reports on a Phase 3 comparison of long-acting versus short-acting LHRH agonists in the treatment of prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Long-acting LHRH agonist
• Short-acting LHRH agonist

Snippet

Sponsor: University of British Columbia | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN